Clinical Trial Update: Hemophilia Adult Prophylaxis Study: Factor VIII in Severe Hemophilia A [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adult prophylaxis with Factor VIII in severe Hemophilia A has been terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Factor VIII (Factor VIII)

Snippet

Sponsor: University of Pittsburgh | Conditions: Severe Hemophilia A | Phase 3 | Status: TERMINATED | Results posted: 2016-09-19